NMA: Nonprescription Medicines Academy

Recent Self Care News

  • Upcoming Health Observances

    • National Cholesterol Education Month
    • National Pediculosis Prevention Month/Head Lice Prevention Month
    • American Pharmacists Month
    • Bone and Joint Health National Awareness Week
    • National Depression Screening Day®
    • American Diabetes Month
    • Gastroesophageal Reflux Disease Awareness Week
    • Great American Smokeout

    August 29th, 2012

  • USPSTF Guideline Recommends Vitamin D for Fall Prevention

    A new recommendation statement from the U.S. Preventive Services Task Force advises vitamin D supplementation in addition to exercise or physical therapy to prevent falls in community-dwelling adults 65 years of age or older who are at increased risk for falls.

    August 1st, 2012

  • Vitamin D Supplementation May Reduce the Burden of Mobility Disability in Older Adults

    Data from the Health, Aging, and Body Composition (Health ABC) study suggest that low serum 25-hydroxyvitamin D concentrations are associated with an increased risk of mobility limitation and disability in older adults.

    August 1st, 2012

  • Draft USPSTF Guidelines Questions Usefulness of Vitamin D, Calcium Supplements for Primary Prevention of Fractures or Cancer

    According to a draft recommendation statement from the U.S. Preventive Services Task Force, daily supplementation with ≤400 IU of vitamin D3 and 1,000 mg of calcium carbonate has no benefit on the incidence of osteoporotic fractures in noninstitutionalized postmenopausal women, and there is inadequate evidence to determine other possible

    August 1st, 2012

  • More Evidence of Link Between Calcium Supplements and Myocardial Infarction Risk

    Data from a prospective cohort study provides new evidence that calcium supplements might increase myocardial infarction risk and should be taken with caution.

    August 1st, 2012

  • Low-Dose Aspirin Associated With 55% Increased Relative Risk of Major Bleeding-But Not in Diabetes

    In a population-based cohort study conducted in Italy, daily use of low-dose aspirin was significantly associated with an increased risk of major gastrointestinal or cerebral bleeding episodes, and the incidence of major bleeding events was five times higher than that reported by the Antithrombotic Trialists’ Collaboration. However, aspirin therapy only marginally increased the risk of bleeding in patients with diabetes.

    August 1st, 2012

  • Low-Dose Aspirin Associated With 55% Increased Relative Risk of Major Bleeding—But Not in Diabetes

    In a population-based cohort study conducted in Italy, daily use of low-dose aspirin was significantly associated with an increased risk of major gastrointestinal or cerebral bleeding episodes, and the incidence of major bleeding events was five times higher than that reported by the Antithrombotic Trialists’ Collaboration. However, aspirin therapy only marginally increased the risk of bleeding in patients with diabetes.

    August 1st, 2012

  • Soy Supplement Provides No Overall Cognitive Benefit in Healthy Postmenopausal Women

    Results of the Women's Isoflavone Soy Health trial indicate that long-term dietary soy isoflavone supplementation in a dose comparable to that of traditional Asian diets has no effect on global cognition in healthy postmenopausal women.

    August 1st, 2012

  • Quick Takes

    • No increased risk of spontaneous abortion with use of nonprescription NSAIDs in early pregnancy
    • NSAIDs may decrease risk of skin cancer
    • Natural Standard launches Adverse Effects Checker
    • Journal of the American Pharmacists Association reviews pharmacist's role in identifying and treating constipation
    • Harris Poll EquiTrend survey reveals consumer preference for “classic” nonprescription brands
    • No benefit from zoster vaccine after recent episode of shingles
    • Editorial focuses on dietary supplement ingredients that could affect thyroid function
    • Baby wash products may produce false positive cannabinoid (THC) screening results

    August 1st, 2012

  • New Product Alerts

    • OraQuick In-Home HIV Test
    • ZzzQuil
    • MenHibrix Vaccine

    August 1st, 2012